Who has invested in Esker Therapeutics?

Foresite Capital are named among the investors backing Esker Therapeutics.

Esker Therapeutics Funding: $70M Raised, Series A (2021)

Esker Therapeutics funding overview

Esker Therapeutics is based in San Francisco, CA. Esker Therapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Esker Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Foresite Capital.

Esker Therapeutics at a glance

Total raised: $70M
Latest round: Series A
Latest round date: May 2021
Headquarters: San Francisco, CA
Notable investors: Foresite Capital

Frequently asked about Esker Therapeutics funding

How much has Esker Therapeutics raised?: Esker Therapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Esker Therapeutics?: Foresite Capital are named among the investors backing Esker Therapeutics.
What was the latest Esker Therapeutics funding round?: The most recent disclosed round is a Series A, announced in May 2021.
Where is Esker Therapeutics based?: Esker Therapeutics is based in San Francisco, CA.
When did Esker Therapeutics last raise?: The last disclosed Esker Therapeutics round closed in May 2021 at Series A.

Totals shown for Esker Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

Esker Therapeutics Funding: $70M Raised, Series A (2021)

Esker Therapeutics funding overview

Esker Therapeutics at a glance

Frequently asked about Esker Therapeutics funding

Companies related to Esker Therapeutics (36)

Browse related funding lists (6)